Oaktree Acquisition Corp. III Life Sciences is a blank check company formed to complete a business combination with one or more target companies. It seeks opportunities in the biopharmaceutical, medical device, diagnostics, and specialized healthcare services sectors in North America and Europe. Until a merger occurs, the company has no operating business or revenue.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 0 | — | 1.9 | — |
| Q3 2025 | 0 | — | 2 | — |
| Q4 2025 | 0 | — | 1.8 | — |
| Q1 2026 | 0 | — | 1.4 | — |
| Q2 2026 | 0 | — | 1.6 | -14.4% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Lantronix, Inc. (LTRX), Syntec Optics Holdings, Inc. (OPTX), Hall Chadwick Acquisition Corp. (HCACU), Deep Fission, Inc. (FISN), Nautilus Biotechnology, Inc. (NAUT), FACT II Acquisition Corp (FACT)